PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Navigation of Key Regulatory Information for Efficient Life-cycle Management of Regulated Product and Application in SINGAPORE
Editorial Archive

Navigation of Key Regulatory Information for Efficient Life-cycle Management of Regulated Product and Application in SINGAPORE

Developing an innovative healthcare product (a drug or a biologic, or a medical device) from the proof-of- concept stage to the marketing stage is an expensive an...
Continue Reading →
CpG OligonucleotideTherapeutics– A History Lesson for CRISPR?
Editorial Archive

CpG OligonucleotideTherapeutics– A History Lesson for CRISPR?

When we look at the emerging and likely future battles being fought to establish dominance in the emerging field of CRISPR technologies, it may be too easy to con...
Continue Reading →
The North of England – An Internationally Recognised Health and Life Science Ecosystem
Editorial Archive

The North of England – An Internationally Recognised Health and Life Science Ecosystem

The North of England’s profile as a hub of health science has been on an impressive trajectory over the past five years. With some of the most illustrious health ...
Continue Reading →
Safety and Regulatory Solutions to Address the Needs of Small and Medium Biopharmaceutical Companies
Editorial Archive

Safety and Regulatory Solutions to Address the Needs of Small and Medium Biopharmaceutical Companies

Small and medium-sized enterprises (SMEs) are often faced with the challenge of having limited resources which can impact their ability to seamlessly move product...
Continue Reading →
Change Management
Editorial Archive

Change Management

The life sciences industry is currently facing unprecedented turmoil. Peter Muller of Schlafender Hase outlines five trends pharma companies will need to weather...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026